Point72 Asia (Singapore)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7,773	Closed	-$29K	–	1308
2024 Q3	$29K	Sell	7,773 -3,839	-33%	-$14.3K	0.01%	770
2024 Q2	$65K	Buy	+11,612	New	+$65K	0.01%	583
2024 Q1	–	Sell	-2,100	Closed	-$11K	–	1274
2023 Q4	$11K	Buy	+2,100	New	+$11K	﹤0.01%	496